
Introduction to a Debilitating Side Effect of Trulicity
As a Trulicity lawyer, I understand that Trulicity is a medication that is commonly used to treat type 2 diabetes. It is a once-weekly injectable medication that belongs to a class of drugs called GLP-1 receptor agonists.
Trulicity works by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels in the body.
By activating the GLP-1 receptors, Trulicity helps promote insulin secretion, reduce glucagon secretion, slow down gastric emptying, and increase satiety. This combination of effects helps to lower blood sugar levels in individuals with type 2 diabetes.
While Trulicity can be an effective treatment option for many individuals with diabetes, it does come with potential side effects such as nausea and stomach pain. Additionally, there is a risk of developing or worsening gastroparesis.
In this article, we will discuss the link between Trulicity and gastroparesis and the legal recourse available for those who developed gastroparesis after taking Trulicity. If you have taken Trulicity and experienced serious Trulicity side effects, such as gastroparesis, you are most likely eligible for a Trulicity lawsuit.

The Link Between Trulicity and Gastroparesis
Gastroparesis is a condition characterized by delayed stomach emptying, resulting in symptoms such as nausea, vomiting, and bloating. While the cause of Gastroparesis is usually unknown, it can be caused by various factors, including diabetes, certain medications, after surgery, high blood pressure, and neurological disorders.
Recently, there has been a rise in reports of individuals who developed gastroparesis after taking Trulicity and had to be taken to the emergency room for extended hospital stays. Trulicity is a prescription medication used to treat type 2 diabetes by improving blood sugar control.
While the exact relationship between Trulicity and gastroparesis is not fully understood, it is important for healthcare providers and patients to be aware of this potentially severe and painful Trulicity side effect.
Trulicity belongs to a class of medications called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). These medications work by increasing insulin secretion, reducing glucagon production, and slowing down digestion. While they are generally well-tolerated, there have been increasing cases of individuals who developed gastroparesis after taking Trulicity.
Indeed, CNN recently reported that at least two people taking the same class of drugs, one taking Ozempic and the other taking Wegovy, have experienced more than just minor stomach issues; these individuals have been diagnosed with gastroparesis, or “paralyzed stomachs”. In addition, Dr. Andrew Boxer, gastroenterologist at Gastroenterology Associates of New Jersey, is among a number of gastroenterologists who said he is seeing an increased number of patients coming into his practice complaining of side effects from these types of drugs.
In an article on Healthline, Dr. Boxer continued stating that “I was seeing a tremendous amount of people coming in just with nausea, vomiting, and feelings of fullness, early satiety, just not feeling well … Universally these patients were on GLP-1’s.”
The exact mechanism by which Trulicity may cause or contribute to the development of gastroparesis is not well understood. It is possible that the medication’s effects on digestion and stomach emptying may play a role. Additionally, individual factors such as pre-existing gastrointestinal conditions or other medications being taken concurrently may also contribute to the development of gastroparesis in individuals using Trulicity.
In cases where Trulicity is suspected to be the cause of gastroparesis, healthcare providers may consider discontinuing the medication and exploring alternative treatment options for managing diabetes. It is important for patients to communicate any changes in their symptoms to their healthcare provider so that appropriate adjustments in treatment can be made.
In conclusion, while Trulicity is generally well-tolerated and effective in managing blood sugar control in individuals with type 2 diabetes, there have been increasing reports of individuals developing gastroparesis after taking this medication. It is crucial for healthcare providers and patients to be aware of this potential Trulicity side effect and monitor for symptoms of gastroparesis.
Prompt communication between patients and healthcare providers is key to ensuring optimal management and treatment in these cases.


